[1] |
Mungroo MR, Anwar A, Khan NA, et al. Brain-eating amoebae infection: challenges and opportunities in chemotherapy[J]. Mini Rev Med Chem, 2019, 19(12): 980-987.
doi: 10.2174/1389557519666190313161854
pmid: 30868950
|
[2] |
Ong TYY, Khan NA, Siddiqui R. Brain-eating amoebae: predilection sites in the brain and disease outcome[J]. J Clin Microbiol, 2017, 55(7): 1989-1997.
doi: 10.1128/JCM.02300-16
pmid: 28404683
|
[3] |
Jahangeer M, Mahmood Z, Munir N, et al. Naegleria fowleri: sources of infection, pathophysiology, diagnosis, and management; a review[J]. Clin Exp Pharmacol Physiol, 2020, 47(2): 199-212.
doi: 10.1111/cep.v47.2
|
[4] |
Geographic range of recreational water-associated primary amebic meningoencephalitis, United States, 1978—2018[J]. Pediatr Infect Dis J, 2021, 40(4): 358.
doi: 10.1097/INF.0000000000003083
|
[5] |
Grace E, Asbill S, Virga K. Naegleria fowleri: pathogenesis, diagnosis, and treatment options[J]. Antimicrob Agents Chemother, 2015, 59(11): 6677-6681.
doi: 10.1128/AAC.01293-15
pmid: 26259797
|
[6] |
Berger JR. Amebic infections of the central nervous system[J]. J Neurovirol, 2022, 28(4/5/6): 467-472.
doi: 10.1007/s13365-022-01096-x
|
[7] |
Capewell LG, Harris AM, Yoder JS, et al. Diagnosis, clinical course, and treatment of primary amoebic meningoencephalitis in the United States, 1937—2013[J]. J Pediatric Infect Dis Soc, 2015, 4(4): e68-e75.
doi: 10.1093/jpids/piu103
|
[8] |
Wang Q, Li JM, Ji JK, et al. A case of Naegleria fowleri related primary amoebic meningoencephalitis in China diagnosed by next-generation sequencing[J]. BMC Infect Dis, 2018, 18(1): 349.
doi: 10.1186/s12879-018-3261-z
|
[9] |
Huang SQ, Liang XA, Han YL, et al. A pediatric case of primary amoebic meningoencephalitis due to Naegleria fowleri diagnosed by next-generation sequencing of cerebrospinal fluid and blood samples[J]. BMC Infect Dis, 2021, 21(1): 1251.
doi: 10.1186/s12879-021-06932-9
|
[10] |
Debnath A. Drug discovery for primary amebic meningoencephalitis: from screen to identification of leads[J]. Expert Rev Anti Infect Ther, 2021, 19(9): 1099-1106.
doi: 10.1080/14787210.2021.1882302
|
[11] |
Güémez A, García E. Primary amoebic meningoencephalitis by Naegleria fowleri: pathogenesis and treatments[J]. Biomolecules, 2021, 11(9): 1320.
doi: 10.3390/biom11091320
|
[12] |
Öcal Demir S, Besli GE, Bucak A, et al. Successful treatment of Acanthamoeba meningoencephalitis in an immunocompetent child[J]. J Trop Pediatr, 2021, 67(2): 102.
|
[13] |
Martínez DY, Bravo-Cossio F, Valdivia-Tapia MDC, et al. Successful treatment of primary amoebic meningoencephalitis using a novel therapeutic regimen including miltefosine and voriconazole[J]. Acta Parasitol, 2022, 67(3): 1421-1424.
doi: 10.1007/s11686-022-00591-9
pmid: 35861895
|
[14] |
Harris GR, Karmarkar EN, Quenelle R, et al. Death from primary amebic meningoencephalitis after recreational water exposure during recent travel to India-Santa Clara County, California, 2020[J]. Open Forum Infect Dis, 2021, 8(8): 322.
|
[15] |
Malik MW, Awan UA, Ahmed H, et al. Environmental surveillance of Naegleria fowleri: a way forward for control of primary amoebic meningoencephalitis cases in Pakista[J]. Travel Med Infect Dis, 2022, 45: 102235.
doi: 10.1016/j.tmaid.2021.102235
|